Tag: car

The acquisition by Heimar hf. ("Heimar" or the "Company") of all shares in Gróska ehf. (“Gróska”) and Gróðurhúsið ehf. (“Gróðurhúsið”) (the “Transaction”), which was initially announced on 23 April this year, has now been completed. 

Data reported from the ongoing ATALANTA-1 Phase 1/2 study in a heavily pretreated relapsed refractory non-Hodgkin’s Lymphoma (R/R NHL) patient population demonstrate low rates of high-grade toxicities

MONTREAL, June 12, 2025 (GLOBE NEWSWIRE) -- Stingray (TSX: RAY. A; RAY.B), an industry leader in music and video content distribution, business services, and advertising solutions, proudly announces its contribution in the grand opening of BMO's new branch at CF Toronto Eaton Centre. This state-of-the-art, full-service branch features Stingray Business's cutting-edge digital signage solutions, highlighting the integration of advanced technology in customer experiences.

The BMO branch in the CF Toronto Eaton Centre is strategically located on the corner of Yonge and  Dundas near Sankofa Square, one of Toronto's busiest intersections and a vibrant hub of innovation and activity. Its two-story wraparound windows presented a unique opportunity to elevate BMO’s brand presence, showcase an innovative approach to marketing, while maintaining a welcoming and comfortable customer experience within the branch. To maximize this unique opportunity, BMO partnered with Stingray Business to implement an innovative digital signage solution.

MAINZ and TÜBINGEN, Germany, June 12, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech”) and CureVac N.V. (Nasdaq: CVAC, “CureVac”) today announced that they have entered into a definitive Purchase Agreement pursuant to which BioNTech intends to acquire all of the shares of CureVac, a clinical-stage biotech company developing a novel class of transformative medicines in oncology and infectious diseases based on messenger ribonucleic acid (“mRNA”). The all-stock transaction will bring together two highly complementary companies based in Germany and will build on BioNTech’s proven track record and established position in the global mRNA industry.